PT Royal Prima Tbk (IDX: PRIM)
Health Care · Health Care Providers & Services · ID
Rp131.00
+6.50% today · +54.1% 1Y
PT Royal Prima Tbk (IDX: PRIM) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $24.73M and employs 797 people.
Over the last twelve months the share price has gained 54.1%, trading between 64.00 and 134.00.
Tweenvest scores PT Royal Prima Tbk across four factors: quality 81/100, value 55/100. Its strongest factor is quality.
PRIM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.73M
- Revenue (TTM)
- $17.93M
- P/E
- —
- EPS
- -5.66
- Dividend yield
- —
- Beta (5Y)
- 0.34
- 52-week high
- Rp134.00
- 52-week low
- Rp64.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.38B
- Employees
- 797
- Next earnings
- —
About PT Royal Prima Tbk
PT Royal Prima Tbk, headquartered in Jakarta, Indonesia, delivers healthcare services across the nation. The company manages hospitals operating under the distinct brands of Royal Prima Medan and Royal Prima Jambi. This enterprise was established in 2013.
- ISIN
- ID1000143209
- Founded
- 2013
- Listed since
- May 17, 2018
- Exchange
- Indonesia Stock Exchange
- Currency
- IDR
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cowealth Medical Holding Co., Ltd.TPEX: 4745 | $25.27M | NT$12.20 | +2.09% |
| Aashka Hospitals LimitedBSE: 543346 | $25.24M | Rs104.45 | -1.00% |
| Microba Life Sciences LimitedASX: MAP | $24.92M | AU$0.05 | +4.08% |
| Japan Hospice Holdings Inc.TSE: 7061 | $24.80M | ¥463.00 | -2.53% |
| Lotus Eye Hospital and Institute LimitedNSEI: LOTUSEYE | $24.48M | Rs113.93 | -1.51% |
| Pharmaceutical Centre S.A.CSE: VITAF | $24.33M | €— | — |
| Cordlife Group LimitedSGX: P8A | $24.25M | S$0.12 | +7.08% |
| Elite Health Systems Inc.OTCPK: EHSI | $24.24M | $0.85 | +21.41% |
Figures last refreshed Oct 11, 2026.